Vascular Supply Chain Acquired by Boston Scientific — Healthcare M&A

Boston Scientific has acquired a vascular supply chain business, a medical devices business in the United States, for $14.5B. The target supports vascular products and related supply capabilities that strengthen Boston Scientific’s position in interventional cardiology and vascular care. Boston Scientific acquisitions in medical devices acquisition categories are aimed at improving manufacturing scale and reliability for vascular device demand. The platform acquisition is part of healthcare M&A led by a strategic buyer, with deal size over $100M and an announced status.